Xencor, Inc.
Bispecific heterodimeric fusion proteins containing IL-15-IL-15R.alpha. Fc-fusion proteins and PD-1 antibody fragments
Last updated:
Abstract:
The present invention is directed to novel bispecific heterodimeric Fc fusion proteins comprising an IL-15/IL-15R.alpha. Fc-fusion protein and a PD-1 antibody fragment-Fc fusion protein.
Status:
Grant
Type:
Utility
Filling date:
16 Oct 2017
Issue date:
4 Feb 2020